Ran Tang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Hematology 11
- Multiple Myeloma Research and Treatments 5
-
- RNA modifications and cancer 6
- Genomics and Phylogenetic Studies 4
- Co-authors
- Zhigang Xu (1 shared paper)Zekuan Xu (7 shared papers)Li Yang (6 shared papers)Xiang Ma (5 shared papers)Chao Yang (5 shared papers)Dakui Luo (3 shared papers)Yi Zhu (4 shared papers)Liqun Liang (3 shared papers)
- Journals
- PLoS ONE (4 papers)Oncotarget (3 papers)Chemical Engineering Journal (3 papers)Frontiers in Oncology (3 papers)Advanced Functional Materials (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Ran Tang
71 papers receiving 1.6k citations
Ran Tang's Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 337
- Hematology 132
- Molecular Biology 631
- Immunology 166
- Biological Psychiatry 16
Countries citing papers authored by Ran Tang
This map shows the geographic impact of Ran Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Tang more than expected).
Fields of papers citing papers by Ran Tang
This network shows the impact of papers produced by Ran Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Tang. The network helps show where Ran Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The China Alzheimer Report 2022 Hit paper breakdown → | 2022 | 243 |
| 2 | Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells‐derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial Hit paper breakdown → | 2023 | 117 |
| 3 | 2015 | 114 | |
| 4 | 2020 | 92 | |
| 5 | 2016 | 85 | |
| 6 | 2014 | 73 | |
| 7 | 2012 | 60 | |
| 8 | 2017 | 51 | |
| 9 | 2022 | 49 | |
| 10 | 2015 | 45 | |
| 11 | 2019 | 41 | |
| 12 | 2023 | 35 | |
| 13 | 2022 | 27 | |
| 14 | 2010 | 27 | |
| 15 | 2013 | 26 | |
| 16 | 2024 | 25 | |
| 17 | 2021 | 24 | |
| 18 | 2022 | 23 | |
| 19 | 2024 | 23 | |
| 20 | 2014 | 22 |
About Ran Tang
Ran Tang is a scholar working on Hematology, Molecular Biology, Cancer Research, Immunology and Neurology, having authored 80 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Multiple Myeloma Research and Treatments (5 papers), Cancer-related molecular mechanisms research (4 papers), Genomics and Phylogenetic Studies (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Alzheimer's disease research and treatments (4 papers), Dementia and Cognitive Impairment Research (3 papers) and Concrete and Cement Materials Research (3 papers). The work is most often cited by research in Cancer Research (337 citations), Hematology (132 citations), Molecular Biology (631 citations), Immunology (166 citations) and Biological Psychiatry (16 citations). Ran Tang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Zhigang Xu, Zekuan Xu, Li Yang, Xiang Ma, Chao Yang, Dakui Luo, Yi Zhu, Liqun Liang, Yumei Chang and Xiaosa Yuan. Their work appears in journals such as PLoS ONE, Oncotarget, Chemical Engineering Journal, Frontiers in Oncology and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.